[
  {
    "ts": "2025-07-23T14:41:00+00:00",
    "headline": "Amyotrophic Lateral Sclerosis (ALS) Market Forecast Report 2025-2034 | Advancements in Therapeutics and Approved Medications Such as Riluzole, Edaravone, and Nuedexta Drive Growth",
    "summary": "The ALS treatment market, valued at USD 791.90 Million in 2024, is forecasted to grow at a CAGR of 5.40% from 2025 to 2034. Rising ALS prevalence, demand for treatments, and advancing research propel growth. Key drugs and therapies from leading companies like Biogen enhance patient outcomes, supported by global healthcare initiatives. Amyotrophic Lateral Sclerosis Market Amyotrophic Lateral Sclerosis Market Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The \"Amyotrophic Lateral Sclerosis Market Repor",
    "url": "https://finance.yahoo.com/news/amyotrophic-lateral-sclerosis-als-market-144100412.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "7b02b4cc-0d4f-3a4e-b29b-97351a8fa7f9",
      "content": {
        "id": "7b02b4cc-0d4f-3a4e-b29b-97351a8fa7f9",
        "contentType": "STORY",
        "title": "Amyotrophic Lateral Sclerosis (ALS) Market Forecast Report 2025-2034 | Advancements in Therapeutics and Approved Medications Such as Riluzole, Edaravone, and Nuedexta Drive Growth",
        "description": "",
        "summary": "The ALS treatment market, valued at USD 791.90 Million in 2024, is forecasted to grow at a CAGR of 5.40% from 2025 to 2034. Rising ALS prevalence, demand for treatments, and advancing research propel growth. Key drugs and therapies from leading companies like Biogen enhance patient outcomes, supported by global healthcare initiatives. Amyotrophic Lateral Sclerosis Market Amyotrophic Lateral Sclerosis Market Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The \"Amyotrophic Lateral Sclerosis Market Repor",
        "pubDate": "2025-07-23T14:41:00Z",
        "displayTime": "2025-07-23T14:41:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/a9399e017b6c9f894df3efc6be5fce68",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Amyotrophic Lateral Sclerosis Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gFYj6r.Fa9jvTTvo7hhJlw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a9399e017b6c9f894df3efc6be5fce68.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kY_.gjCVeAtrY3wrJVnWOg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a9399e017b6c9f894df3efc6be5fce68.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amyotrophic-lateral-sclerosis-als-market-144100412.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amyotrophic-lateral-sclerosis-als-market-144100412.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]